As expected, the tumor samples with metastasis status: M1 (spread to other parts of the body patients) were dramatically enriched in the sub-groups of KIRC patients harboring high-expression of the RIPK2 gene (P < 0.0001, Figure 7A). The gene discussed is RIPK2; the disease is neoplasm.